Mark Schusterman, MD
Plastic and Reconstructive Surgery · Temple, TXNPI 1366872020
Payments from drug & device makers
What this record shows
This record is dominated by other: $22,954 of the $27,780 with a category attached, or 82.6%. Johnson & Johnson accounts for 82.6% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $24,059, more than ten times the $144 reported in 2019. Among plastic and reconstructive surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $283.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$23K
- TELA Bio, Inc.$2K
- AbbVie$1K
- Integra Lifesciences Corporation$270
- Davol Inc.$259
- Kerecis Limited$199
- plus $1K from 19 others
What the payments were for
- Consulting fees$1,0004%
- Travel & lodging$220%
- Food & beverage$3,80514%
- Other$22,95483%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $22,954 |
| TELA Bio, Inc. | 17 | $1,766 |
| AbbVie(2 entities) | 22 | $1,018 |
| Integra Lifesciences Corporation | 6 | $270 |
| Davol Inc. | 4 | $259 |
| Kerecis Limited | 6 | $199 |
| Revance Therapeutics, Inc. | 3 | $178 |
| Axogen | 7 | $176 |
| Sientra, Inc. | 3 | $163 |
| Stryker | 3 | $136 |
| Avita Medical Americas, LLC | 2 | $114 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $102 |
| RTI Surgical, Inc | 4 | $74 |
| Elucent Medical | 2 | $56 |
| Acera Surgical, Inc. | 2 | $47 |
| Medical Device Business Services, Inc. | 2 | $38 |
| KCI USA, Inc. | 2 | $38 |
| Medtronic | 1 | $34 |
| Smith+Nephew | 1 | $33 |
| Lifenet Health | 1 | $31 |
| W. L. Gore & Associates, Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Solventum Corporation | 1 | $20 |
| Baxter Healthcare | 1 | $16 |
| Coopersurgical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,780 in reported general payments places this provider in the 90th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 20 | $594 |
| Gabapentin | 24 | $146 |
| Oxycodone Hcl | 19 | $74 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Temple
- Aldona SpiegelHouston$759K
- Charles ButlerHouston$227K
- Michael KlebucHouston$204K
- Joshua LemmonRichardson$118K
- Patrick GarveyHouston$117K
- Rukmini RednamHouston$113K
- Edward ChangHouston$111K
- Alina SholarAustin$110K
- Ashley SteinbergBellaire$102K
- Eric MinnsLubbock$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.